Pipecuronium
As of the edition of 20 October 2026, Pipecuronium is a small molecule: marketed, first approved in 1990 (US); acts on CHRNA1; no US protection is listed.
Sources: FDA Orange Book and Purple Book, other approval registers, ClinicalTrials.gov, ChEMBL.
The drug
- Status
- Marketed; latest approval 1990
- Kind
- Small molecule
- Brand name
- Arduan
- First approved
- 26 June 1990 (US)
- Approvals on record
- 1 in 1 region
- Holder of the most recent approval
- Organon
- Registered trials
- 2, 0 stopped early
US protection
No US protection is listed.
The FDA registers list no drug-substance patent or exclusivity that counts for this drug.
This is the US only.
Target
| Gene | Protein | UniProt |
|---|---|---|
| CHRNA1 | Acetylcholine receptor subunit alpha | P02708 |
Registered trials
| Phase | Trials | Completed | Active | Stopped early |
|---|---|---|---|---|
| Phase 4 | 2 | 0 | 2 | 0 |
| All trials | 2 |
Who has held its approvals
| Company | Role | Years |
|---|---|---|
| Organon | Acquired holder and Earlier holder | 1990 to now |